|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lengyel E: Ovarian cancer development and
metastasis. Am J Pathol. 177:1053–1064. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tan DS, Agarwal R and Kaye SB: Mechanisms
of transcoelomic metastasis in ovarian cancer. Lancet Oncol.
7:925–934. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gadducci A, Cosio S, Zola P, Sostegni B,
Ferrero AM, Teti G, Cristofani R and Sartori E: The clinical
outcome of epithelial ovarian cancer patients with apparently
isolated lymph node recurrence: A multicenter retrospective Italian
study. Gynecol Oncol. 116:358–363. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mutch DG and Prat J: 2014 FIGO staging for
ovarian, fallopian tube and peritoneal cancer. Gynecol Oncol.
133:401–404. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kleppe M, Wang T, Van Gorp T, Slangen BF,
Kruse AJ and Kruitwagen RF: Lymph node metastasis in stages I and
II ovarian cancer: A review. Gynecol Oncol. 123:610–614. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pereira A, Magrina JF, Rey V, Cortes M and
Magtibay PM: Pelvic and aortic lymph node metastasis in epithelial
ovarian cancer. Gynecol Oncol. 105:604–608. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Camara O and Sehouli J: Controversies in
the management of ovarian cancer-pros and cons for lymph node
dissection in ovarian cancer. Anticancer Res. 29:2837–2843.
2009.PubMed/NCBI
|
|
9
|
Trimbos JB: Lymphadenectomy in ovarian
cancer: Standard of care or unnecessary risk. Curr Opin Oncol.
23:507–511. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
di Re F, Baiocchi G, Fontanelli R, Grosso
G, Cobellis L, Raspagliesi F and di Re E: Systematic pelvic and
paraaortic lymphadenectomy during cytoreductive surgery in advanced
ovarian cancer: Potential benefit on survival. Gynecol Oncol.
62:360–365. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Scarabelli C, Gallo A, Zarrelli A,
Visentin C and Campagnutta E: Systematic pelvic and para-aortic
lymphadenectomy during cytoreductive surgery in advanced ovarian
cancer: Potential benefit on survival. Gynecol Oncol. 56:328–337.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Di Re F and Baiocchi G: Value of lymph
node assessment in ovarian cancer: Status of the art at the end of
the second millennium. Int J Gynecol Cancer. 10:435–442. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shaw TJ, Senterman MK, Dawson K, Crane CA
and Vanderhyden BC: Characterization of intraperitoneal, orthotopic
and metastatic xenograft models of human ovarian cancer. Mol Ther.
10:1032–1042. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ricci F, Broggini M and Damia G:
Revisiting ovarian cancer preclinical models: Implications for a
better management of the disease. Cancer Treat Rev. 39:561–568.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lengyel E, Burdette JE, Kenny HA, Matei D,
Pilrose J, Haluska P, Nephew KP, Hales DB and Stack MS: Epithelial
ovarian cancer experimental models. Oncogene. 33:3619–3633. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Servais EL, Colovos C, Bograd AJ, White J,
Sadelain M and Adusumilli PS: Animal models and molecular imaging
tools to investigate lymph node metastases. J Mol Med (Berl).
89:753–769. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kang Y, Pu T, Cai Q, Hong S, Zhang M, Li
G, Zhu Z and Xu C: Identification of lymphatic metastasis
associated genes in a metastatic ovarian cancer cell line. Mol Med
Rep. 12:2741–2748. 2015.PubMed/NCBI
|
|
18
|
Xiong L, Shuhendler AJ and Rao J:
Self-luminescing BRET-FRET near-infrared dots for in vivo
lymph-node mapping and tumour imaging. Nat Commun. 3:11932012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Painter JT, Clayton NP and Herbert RA:
Useful immunohistochemical markers of tumor differentiation.
Toxicol Pathol. 38:131–141. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pereira A, Pérez-Medina T, Magrina JF,
Magtibay PM, Rodríguez-Tapia A, de León J, Peregrin I and
Ortiz-Quintana L: Correlation between the extent of intraperitoneal
disease and nodal metastasis in node-positive ovarian cancer
patients. Eur J Surg Oncol. 40:917–924. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Classe JM, Cerato E, Boursier C, Dauplat
J, Pomel C, Villet R, Cuisenier J, Lorimier G, Rodier JF, Mathevet
P, et al: Retroperitoneal lymphadenectomy and survival of patients
treated for an advanced ovarian cancer: The CARACO trial. J Gynecol
Obstet Biol Reprod (Paris). 40:201–204. 2011.(In French).
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Signorelli M, Guerra L, Pirovano C,
Crivellaro C, Fruscio R, Buda A, Cuzzucrea M, Elisei F, Ceppi L and
Messa C: Detection of nodal metastases by 18F-FDG PET/CT in
apparent early stage ovarian cancer: A prospective study. Gynecol
Oncol. 131:395–399. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kitajima K, Murakami K, Yamasaki E, Kaji
Y, Fukasawa I, Inaba N and Sugimura K: Diagnostic accuracy of
integrated FDG-PET/contrast-enhanced CT in staging ovarian cancer:
Comparison with enhanced CT. Eur J Nucl Med Mol Imaging.
35:1912–1920. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bristow RE, Giuntoli RL II, Pannu HK,
Schulick RD, Fishman EK and Wahl RL: Combined PET/CT for detecting
recurrent ovarian cancer limited to retroperitoneal lymph nodes.
Gynecol Oncol. 99:294–300. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pannu HK, Cohade C, Bristow RE, Fishman EK
and Wahl RL: PET-CT detection of abdominal recurrence of ovarian
cancer: Radiologic-surgical correlation. Abdom Imaging. 29:398–403.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
van Dam GM, Themelis G, Crane LM, Harlaar
NJ, Pleijhuis RG, Kelder W, Sarantopoulos A, de Jong JS, Arts HJ,
van der Zee AG, et al: Intraoperative tumor-specific fluorescence
imaging in ovarian cancer by folate receptor-alpha targeting: First
in-human results. Nat Med. 17:1315–1319. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Satpathy M, Wang L, Zielinski R, Qian W,
Lipowska M, Capala J, Lee GY, Xu H, Wang YA, Mao H and Yang L:
Active targeting using HER-2-affibody-conjugated nanoparticles
enabled sensitive and specific imaging of orthotopic HER-2 positive
ovarian tumors. Small. 10:544–555. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ren G, Webster JM, Liu Z, Zhang R, Miao Z,
Liu H, Gambhir SS, Syud FA and Cheng Z: In vivo targeting of
HER2-positive tumor using 2-helix affibody molecules. Amino Acids.
43:405–13. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Miao Z, Ren G, Jiang L, Liu H, Webster JM,
Zhang R, Namavari M, Gambhir SS, Syud F and Cheng Z: A novel
18F-labeled two-helix scaffold protein for PET imaging of
HER2-positive tumor. Eur J Nucl Med Mol Imaging. 38:1977–1984.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Schols RM, Connell NJ and Stassen LP:
Near-infrared fluorescence imaging for real-time intraoperative
anatomical guidance in minimally invasive surgery: A systematic
review of the literature. World J Surg. 39:1069–1079. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Harlaar NJ, Kelder W, Sarantopoulos A,
Bart J, Themelis G, van Dam GM and Ntziachristos V: Real-time near
infrared fluorescence (NIRF) intra-operative imaging in ovarian
cancer using an α(v)β(3-)integrin targeted agent. Gynecol Oncol.
128:590–595. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
van der Vorst JR, Schaafsma BE, Verbeek
FP, Swijnenburg RJ, Hutteman M, Liefers GJ, van de Velde CJ,
Frangioni JV and Vahrmeijer AL: Dose optimization for near-infrared
fluorescence sentinel lymph node mapping in patients with melanoma.
Br J Dermatol. 168:93–98. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cahill RA, Anderson M, Wang LM, Lindsey I,
Cunningham C and Mortensen NJ: Near-infrared (NIR) laparoscopy for
intraoperative lymphatic road-mapping and sentinel node
identification during definitive surgical resection of early-stage
colorectal neoplasia. Surg Endosc. 26:197–204. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Troyan SL, Kianzad V, Gibbs-Strauss SL,
Gioux S, Matsui A, Oketokoun R, Ngo L, Khamene A, Azar F and
Frangioni JV: The FLARE intraoperative near-infrared fluorescence
imaging system: A first-in-human clinical trial in breast cancer
sentinel lymph node mapping. Ann Surg Oncol. 16:2943–2952. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yamashita S, Tokuishi K, Miyawaki M, Anami
K, Moroga T, Takeno S, Chujo M, Yamamoto S and Kawahara K: Sentinel
node navigation surgery by thoracoscopic fluorescence imaging
system and molecular examination in non-small cell lung cancer. Ann
Surg Oncol. 19:728–733. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kubota K, Yoshida M, Kuroda J, Okada A,
Ohta K and Kitajima M: Application of the hypereye medical system
for esophageal cancer surgery: A preliminary report. Surg Today.
43:215–220. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tajima Y, Murakami M, Yamazaki K, Masuda
Y, Kato M, Sato A, Goto S, Otsuka K, Kato T and Kusano M: Sentinel
node mapping guided by indocyanine green fluorescence imaging
during laparoscopic surgery in gastric cancer. Ann Surg Oncol.
17:1787–1793. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hutteman M, van der Vorst JR, Gaarenstroom
KN, Peters AA, Mieog JS, Schaafsma BE, Löwik CW, Frangioni JV, van
de Velde CJ and Vahrmeijer AL: Optimization of near-infrared
fluorescent sentinel lymph node mapping for vulvar cancer. Am J
Obstet Gynecol. 206:89. e1–e5. 2012. View Article : Google Scholar
|
|
39
|
van der Vorst JR, Hutteman M, Gaarenstroom
KN, Peters AA, Mieog JS, Schaafsma BE, Kuppen PJ, Frangioni JV, van
de Velde CJ and Vahrmeijer AL: Optimization of near-infrared
fluorescent sentinel lymph node mapping in cervical cancer
patients. Int J Gynecol Cancer. 21:1472–1478. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Holloway RW, Bravo RA, Rakowski JA, James
JA, Jeppson CN, Ingersoll SB and Ahmad S: Detection of sentinel
lymph nodes in patients with endometrial cancer undergoing
robotic-assisted staging: A comparison of colorimetric and
fluorescence imaging. Gynecol Oncol. 126:25–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Van den Broeck W, Derore A and Simoens P:
Anatomy and nomenclature of murine lymph nodes: Descriptive study
and nomenclatory standardization in BALB/cAnNCrl mice. J Immunol
Methods. 312:12–19. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Shaner NC, Steinbach PA and Tsien RY: A
guide to choosing fluorescent proteins. Nat Methods. 2:905–909.
2005. View Article : Google Scholar : PubMed/NCBI
|
